• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edap Tms Sa ADR (NQ: EDAP )

    2.565 -0.165 (-6.04%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Edap Tms Sa ADR

    < Previous 1 2 3 4 Next >
    EDAP Reports Third Quarter 2024 Financial Results
    From EDAP TMS S.A.
    Via GlobeNewswire
    A Glimpse of Edap TMS's Earnings Potential
    Via Benzinga
    EDAP to Participate in the 2024 Jefferies London Healthcare Conference
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
    From EDAP TMS S.A.
    Via GlobeNewswire
    Earnings Outlook For Edap TMS
    Via Benzinga
    EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Reports Second Quarter 2024 Financial Results
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Appoints Fran Schulz to Board of Directors
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP to Present at the Jefferies Global Healthcare Conference
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q1 2024
    EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    EDAP Reports First Quarter 2024 Financial Results
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023
    EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
    From EDAP TMS S.A.
    Via GlobeNewswire
    Earnings Scheduled For March 27, 2024
    Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
    Via Benzinga
    EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
    From EDAP TMS S.A.
    Via GlobeNewswire
    EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
    From EDAP TMS S.A.
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.